The RGD (CRGDKGPDC; iRGD) modified endostatin, which showed specific and increased binding to endothelial cells was more effective than human endostatin in inhibiting liver cancer growth in athymic mice [32]. The gene discussed is COL18A1; the disease is liver cancer.